Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	-40.37	47.60	79.82
Graham Fair Price	15.11	45.32	39.37
PEG	-76.09	0.62	-2.58
Price/Book	-19.06	-35.58	-29.88
Price/Cash Flow	-97.05	18.08	613.45
Prices/Earnings	-14.89	22.16	26.04
Price/Sales	21.10	0.92	0.76
Price/FCF	-97.05	18.08	613.45
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	16.40	0.05	0.04
Operating Margin	126.42	0.02	< 0.005
ROA	32.44	0.01	< 0.005
ROE	-0.29	-0.40	-39.88
ROIC	0.12	0.26	115.86
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	-0.03	0.04	-28.21
Dividends QOQ	0.12	< 0.005	-98.70
EBIT QOQ	-0.32	1.14	249.95
EPS QOQ	-0.10	0.36	255.96
FCF QOQ	-0.88	37.78	4199.10
Revenue QOQ	0.05	-0.06	17.73
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	25.49	26.10	2.39
Days Sales Outstanding (DSO)	25.66	25.49	-0.68
Inventory Turnover	3.53	3.45	-2.34
Debt/Capitalization	1.37	1.52	10.99
Quick Ratio	0.48	0.50	3.24
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	-15.49	-15.08	2.67
Cash	14.96	35.08	134.52
Capex	-1.16	-2.06	-77.08
Free Cash Flow	0.75	29.67	3831.41
Revenue	610.55	584.20	-4.32
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	0.92	0.92	-0.65
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	6.71	1.83	-72.70
Naive Interpretation	Member

06 - Financial Health · Bad

Rating